Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chylomicronemia syndrome].

Adi Francis1, Yishai Levy

  • 1Department of Medicine A, Haemek Medical Center, Afula.

Harefuah
|March 22, 2002
PubMed
Summary

Chylomicronemia syndrome involves severe high triglycerides, leading to pancreatitis risk. Treatment targets both genetic and acquired causes for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis.

Vaccine: X·2023
Same author

Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' reply.

Alimentary pharmacology & therapeutics·2022
Same author

Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis.

Alimentary pharmacology & therapeutics·2021
Same author

A Friend and a Foe: 50 Years of the Apolipoprotein E Research Trail.

The Israel Medical Association journal : IMAJ·2021
Same author

[REDUCTION OF ANTIBIOTIC CONSUMPTION IN RAMBAM HEALTH CARE CAMPUS - THE ROLE OF AN ANTIBIOTIC STEWARDSHIP PROGRAM].

Harefuah·2017
Same author

Green tea, weight loss and physical activity.

Clinical nutrition (Edinburgh, Scotland)·2016

Area of Science:

  • Metabolic disorders
  • Lipid metabolism

Context:

  • Chylomicronemia syndrome is a severe hypertriglyceridemia condition.
  • Characterized by massive chylomicron accumulation in plasma.

Purpose:

  • To review the pathophysiology, diagnosis, prevalence, and treatment of chylomicronemia syndrome.
  • To discuss genetic and acquired causes contributing to the condition.

Summary:

  • Severe hypertriglyceridemia and chylomicron accumulation define chylomicronemia syndrome.
  • Clinical manifestations include eruptive xanthomas, lipemia retinalis, and pancreatitis risk (triglycerides > 2000 mg/dl).
  • Genetic causes include lipoprotein lipase deficiency, apolipoprotein C-II deficiency, and LPL inhibitor. Acquired factors include diabetes, certain drugs, and alcohol.

Impact:

  • Highlights the importance of identifying and treating both familial and acquired contributors to chylomicronemia syndrome.
  • Provides a comprehensive overview for clinicians and researchers managing patients with severe hypertriglyceridemia.

Related Experiment Videos